The 7 analysts offering 12-month price forecasts for Cytosorbents Corp have a median target of 15.00, with a high estimate of 17.00 and a low estimate of 13.00. The median estimate represents a +81.38% increase from the last price of 8.27.
The current consensus among 7 polled investment analysts is to Buy stock in Cytosorbents Corp. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.04
Reporting Date Aug 10
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.